Pharmacology: Entecavir is a guanosine nucleoside analogue with potent and selective activity against HBV polymerase. For pharmacological action, it is phosphorylated to the active triphosphate (TP) form. Entecavir triphosphate functionally inhibits all 3 activities of the viral polymerase; priming of the HBV polymerase, reverse transcription of the negative strand from the pregenomic messenger RNA and synthesis of the positive strand HBV DNA.